Clinical Trial

Multimodal Imaging and Digital Pathology for Prostate Cancer Prediction

Recruiting
View on ClinicalTrials.gov →
Summary
This is a multicenter observational study. A deep learning model integrated with multimodal imaging and digital pathology spatial registration is built based on preoperative multiparametric magnetic resonance imaging, transrectal ultrasound and postoperative digital pathological whole slide images. The study is designed to achieve accurate prediction of clinically significant prostate cancer and non-invasive risk stratification. Unnecessary prostate biopsy and overdiagnosis can be reduced to support the optimization of clinical diagnosis and treatment strategies.
Trial Details
NCT Number NCT07614256
Lead Sponsor Guangxi Medical University
Conditions Prostate Cancer (Diagnosis), Clinically Significant Prostate Cancer
Enrollment 3,000 participants
Start Date 2025-05-30
Primary Completion 2030-06-30 (estimated)
Study Completion 2030-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-29